Research ArticleOriginal Article

Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer

Yimeng Chen, Xue Wang, Feng Du, Jian Yue, Yiran Si, Xiaochen Zhao, Lina Cui, Bei Zhang, Ting Bei, Binghe Xu and Peng Yuan
Cancer Biology & Medicine February 2023, 20 (2) 155-168; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0525

Article Information

vol. 20 no. 2 155-168
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2022.0525
Published By 
Cancer Biology & Medicine
History 
  • Received August 26, 2022
  • Accepted November 28, 2022
  • Published online March 2, 2023.
Copyright & Usage 
Copyright: © 2023, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Yimeng Chen1,*,
  2. Xue Wang2,*,
  3. Feng Du1,
  4. Jian Yue2,
  5. Yiran Si1,
  6. Xiaochen Zhao3,
  7. Lina Cui3,
  8. Bei Zhang3,
  9. Ting Bei3,
  10. Binghe Xu1⇑ and
  11. Peng Yuan2⇑
  1. 1Department of Medical Oncology and Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  2. 2Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  3. 3The Medical Department, 3D Medicines Inc., Shanghai 201114, China
  1. Correspondence to: Peng Yuan and Binghe Xu, Email: yuanpengyp01{at}163.com and xubinghebm{at}163.com
View Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords